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The present study demonstrates the postprandial hypoglycemic effects of methanol root extract of Mirabilis 
jalapa. Alloxan induced diabetic rats were treated with 200 mg/kg body weight of the extract for 9 days at 
12 hourly intervals. The experiment was designed to assess both fasting and 2 hour postprandial blood 
glucose levels. Lipid profile and liver function biochemical analyses were conducted using serum obtained 
from the experimental animals sacrificed after 10 days. The results showed a marked difference in blood 
glucose levels postprandial in the diabetic group treated with the extract (DTM) (11.02 ± 1.42 mmol/L) 
when compared with the diabetic untreated group (DU) (19.80 ± 5.37 mmol/L). Similar trends were 
observed for the fasting blood glucose which remained elevated in the DU group throughout the experiment 
but was maintained at comparable levels (4.70 – 6.82 mmol/L) between healthy control group (HU) and all 
other groups treated both with extract and standard drug metformin. Triglyceride levels of diabetic groups 
treated with the extract were also observed to fall within comparable limits with the HU group (30.79 ±4.76 
– 65.95 ± 2.42 mg/L). In conclusion, treatment with methanol root extract of Mirabilis jalapa suppresses 
hyperglycemia postprandial and probably promotes slow progression to dyslipidemia in experimentally 
induced diabetes in rats. 
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INTRODUCTION 
The global prevalence of diabetes has been on a 
steady rise since 1980s. By 2014, an estimated 
422 million adults were living with the disease 
(WHO, 2016). This figure is projected to rise to 
592 million by 2035 (Guariguata et al., 2014). 
Recent findings indicates an alarming trend of  
diabetes (about 8.6% prevalence) in low-middle 
income countries (LIMC) most of whom live in 
rural areas (Hwang et al., 2012; Zebetian et al., 
2014). According to Ogurtsova et al. (2017), 75% 
of people living with diabetes live in low and 
middle income countries and this region (Afirca 
and Middle East) is projected to experience high 
growth in people living with diabetes (140.7% 
increase by 2040).  
 
Rural populations especially in African 
communities depend on medicinal plants for 
treatment of various ailments. Preparations of 
medicinal plants either as extractives or as part of 
dietary recipe in the treatment of diabetes 
mellitus are common practice in different ethnic 
groups in Nigeria (Ezuruike and Prieto, 2014). 
Among other reasons such as cultural beliefs, 
poor accessibility, scarcity and cost of 
prescription drugs, overstretched health care 
facilities in these communities are common 
factors that influence the resort to alternative 
means for treatment. Most often than not, 
medicinal plants are considered the solution to 
this problem.  
 
Mirabilis jalapa commonly known as “four o’clock” 
plant (Holdsworth, 1992) and locally as tonaposo 
in Yoruba language (Elufioye et al., 2012) 
belongs to the family Nyctaginaceae. It is 
commonly used in Chinese folk medicine to treat 
diabetes (Zhou et al., 2012a), constipation (Lee 
et al., 2008), genitourinary system disorder and 
injuries (Weckerle et al., 2009). It is also widely 
used to treat dysentery, diarrhea (Sadiq et al., 
2016) muscular pain, and abdominal colics 
(Walker et al., 2008). Its extract has antibacterial 
Sadiq et al: Treatment with Methanol Root Extract of Mirabilis jalapa Suppresses…………….. 
60 
(Eneji et al., 2011) antiviral, and antifungal 
functions (Vivanco et al., 1999). This study 
examines the hypoglycemic and antidyslipidemic 
effects of oral administration of root extracts of 
the plant in alloxan induced hyperglycemic rats 
as compared to treatment with metformin. 
 
MATERIALS AND METHODS 
Materials  
All chemicals and reagents used were as 
follows: absolute methanol (Sigma Aldrich, 
USA), test kits for lipid profile and liver function 
tests (Randox, Northern Ireland). The chemical 
alloxan monohydrate was kindly donated by the 
Department of Biochemistry, Usmanu Danfodiyo 
University, Sokoto. A glucometer (Finetest, 
model number IGM-0017B, Infopia Co ltd, 
Korea) was used for blood glucose tests. 
Equipment used included rotary evaporator 
(Cole-parmer 115VAC), spectrophotometer 
(AMEX SQ2800), centrifuge (110V desktop 
electric) and drying chamber.  
 
Plant Material 
The whole plant M. jalapa was obtained from 
Igabi local government area, Kaduna State and 
identified by a botanist at the Herbarium of the 
Department of Biological Sciences, Ahmadu 
Bello University, Zaria with a specimen voucher 
number 2441. The roots were cut into small 
pieces, dried (under shade) to a constant dry 
weight, subsequently grinded using pestle and 
mortar and stored until required. 
 
Experimental Animals 
Twenty-five (25) wistar albino rats weighing 
between 0.14-0.22kg were used for this study. 
The animals were obtained from Abraham 
farms, Kaduna and transported to the animal 
house of Department of Biochemistry, Faculty of 
Science, Usmanu Danfodiyo University (UDU), 
Sokoto. In accordance with the Approval and 
guidelines of the ethical committee, Department 
of Biochemistry, UDU, Sokoto, the animals were 
housed in well ventilated plastic cages at 25ºC 
and were fed with pelleted growers feed (Vital 
feeds, UAC foods) and water ad libitum prior to 
experimentation. The rats were allowed to 
acclimatize for two weeks.  
 
METHODOLOGY 
Plant Material Extraction 
Exactly 1 kg of ground M. jalapa root was 
macerated in 4 litres of absolute methanol and 
left in an air tight aspirator bottle for 72hours. The 
preparation was filtered first using muslin cloth 
then Whatmann filter paper number 1. The filtrate 
was concentrated with the aid of a rotary 
evaporator and drying cabinet set at 45°C. The 
concentrated extract was kept in a CaCl2 
containing desiccator.  
 
Experimental Design 
After acclimatization, the animals were grouped 
according to their body weights into five groups of 
five animals per group and were labeled as 
follows: Group 1: diabetic untreated rats (DU); 
Group 2: healthy untreated rats (HU); Group 3: 
diabetic rats treated with M. jalapa methanol 
extract (DTM); Group 4: diabetic rats treated with 
standard drug metformin (DTS); Group 5: healthy 
rats treated with M. jalapa methanol extract 
(HTM). Hyperglycemia was induced in the groups 
DU, DTM and DTS by subcutaneous 
administration of alloxan monohydrate at a dose 
of 100 mg/kg body weight per day for three days. 
The animals were given glucose solution to 
prevent hypoglycemia. The procedure was 
repeated until hyperglycemia was confirmed 
using a glucometer strip test. Animals with fasting 
blood glucose levels (FBS) >11.0 mmol/L were 
considered hyperglycemic and were included in 
the study.  
 
Treatment of Experimental Animals 
The experimental animals were treated with a 
dose of 200 mg/kg body weight administered 
orally at 12 hourly intervals (12am and 12pm) for 
9 days. The rats were fasted for 6 hours (12 am-6 
am); after which blood samples were collected 
from the tail for measurement of fasting blood 
sugar levels using a glucometer. The animals 
were then allowed access to feed for 2 hours and 
blood glucose measurement was again taken. 
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The animals were humanely sacrificed on day 10, 
blood samples collected in heparinized tubes, 
centrifuged at 4000rpm and serum obtained was 
used for assessment of lipid profile and liver 
function biochemical parameters according to 
manufacturer’s procedure described in 
purchased test kits. 
 
Statistical Analysis 
All data were expressed as mean ± standard 
deviation. Student T-test was used to compare 
treatments (p<0.05) while differences in group 
treatments was analyzed by one-way analysis of 
variance (ANOVA) with tukey post-hoc test using 
instant 3 software (p<0.05). Spearman’s 
Correlation was conducted to show relationship 
between blood glucose and lipid profile as 
influenced by treatments administered. 
 
RESULTS 
Table 1 shows the Fasting Blood Glucose (FBG) 
levels of experimental animals treated with 
methanol root extracts of M. jalapa. The 
untreated diabetic group (DU) had a sustained 
hyperglycemia throughout the experimental 
period. No significant difference (p<0.05) in the 
blood glucose levels of the treated diabetic 
groups DTM and DTS when compared with the 
untreated diabetic group (DU) on day 1 (before 
treatment). By day 4 however, a significant drop 
in fasting blood glucose (5.46±0.04 mmol/L) was 
observed in the DTM group which was not 
significantly different (p>0.05) from the healthy 
control groups (HU and HTM). Results of 2 hour 
postprandial (2HPP) blood glucose show that  
treatment with methanol root extract of the plant 
significantly lowered (p<0.05) blood glucose 
levels postprandial as treatment progressed. The 
values recorded for the diabetic treated group 
DTM (8.60±2.20 mmol/L) compared with that 
observed for the healthy treated group 
(5.78±0.39 mmol/L) as at day 10. 
 
Differences in average values of FBG and 2HPP 
treatments on days 4 and 7 (Figure 1) were 
significant (p<0.05) in diabetic animals (DTM) 
treated with the extract. The untreated diabetic 
group (DU) however had elevated blood sugar 
levels for both treatments throughout the 




Table 1: Effect of oral administration of methanol extracts of Mirabilis jalapa roots on fasting blood sugar 
(FBS) levels of experimental animals. 
 FBS (mmol/L) 





Day 4 Day 7 Day 10 
DU 5.30±0.65a 15.90±2.45a 15.10±1.37b 15.40±4.74a 10.42±2.97b 
HU 5.34±0.63a 5.34±0.63b 5.00±0.98a 4.78±0.47b 4.70±0.36a 
HTM 5.10±0.60a 5.10±0.60b 3.32±1.06a 5.60±0.26b 4.98±0.13a 
DTM 6.50±0.17a 15.60±3.81a 5.46±0.40a 6.62±1.10b 6.28±1.29a 
DTS 6.02±0.39a 19.60±4.34a 13.78±4.53b 11.80±3.28a 6.82±0.40a 
Data are expressed as mean ± standard deviation, n=5. Values bearing different superscript within a particular column differ 
significantly (p<0.05). 
Key: DU: Diabetic untreated rats (diabetic control); HU: Healthy untreated rats (normal control); HTM: Healthy rats treated with 
M. jalapa extract; DTM: Diabetic treated with M. jalapa extract; DTS: Diabetic treated with standard drug. 
Sadiq et al: Treatment with Methanol Root Extract of Mirabilis jalapa Suppresses…………….. 
62 
Table 2: Effect of oral administration of methanolic extracts of Mirabilis jalapa L. roots on 2 hours post-
prandial blood glucose (2HPP) of experimental rats. 
   2HPP(mmol/L) 
Groups  Before alloxan 
induction 
Day 1                        
(No treatment) 
Day 4 Day 7 Day 10 
DU 5.30±0.65 15.90±2.45a 17.62±2.82a 19.80±5.37a 24.24±2.96a 
HU 5.34±0.63 5.34±0.63 b 6.00±0.50b 5.96±0.27b 5.88±0.14b 
HTM 5.10±0.60 5.10±0.60 b 6.38±1.46b 6.28±0.10b 5.78±0.39b 
DTM 6.50±0.17 15.60±3.81a 12.36±1.43a,b 11.02±1.42b,c 8.60±2.20b,d 
DTS 6.02±0.39 19.60±4.34 a 18.10±4.08a 14.24±3.12a,c 12.26±3.93c,d 
Data are expressed as mean ± standard deviation, n=5. Values bearing different superscript within a particular column differ 
significantly (p<0.05)  
Key: DU: Diabetic untreated rats (diabetic control); HU: Healthy untreated rats (normal control); HTM: Healthy rats treated with 
M. jalapa extract; DTM: Diabetic treated with M. jalapa extract; DTS: Diabetic treated with standard drug 
 
 
Figure 1: Comparison of FBS and 2HPP of 
experimental rats treated with methanol extracts 
of Mirabilis jalapa L. roots. 
Key: DU: Diabetic untreated rats (diabetic control); HU: 
Healthy untreated rats (normal control); HTM: Healthy rats 
treated with M. jalapa extract; DTM: Diabetic treated with 
M. jalapa extract; DTS: Diabetic treated with standard drug 
metformin  
 
Effects of administration of methanol root extract 
of the plant on indices of liver function indicated 
an elevation in total proteins in the diabetic 
untreated (DU) and all treated groups (HTM, 
DTM and DTS) in the range 42.36±3.10 – 
43.74±2.67 g/dL when compared with the healthy 
control group HU (21.93±4.60 g/dL). Although 
albumin levels in all the groups were comparable, 
the AST and ALT levels in the DTM group were 
significantly different (p<0.05) from values 
observed for the DU and DTS groups (Table 3) 
 
The lipid profile of experimental animals (Figure 
2) shows the total glyceride levels (TAG) of 
treated groups DTM and DTS were significantly 
different (p<0.05) from the diabetic untreated 
group (DU). A similar trend was observed for the 
VLDL-C levels, where values observed for DTS 
and DTM were between 13.15±0.49 and 
15.72±0.63 mg/dL as compared to 25.11±0.27 
mg/dL recorded for the diabetic untreated group. 
A significant difference (p<0.05) was also 
observed for HDL-C levels between the diabetic 
untreated group and treated diabetic groups  but 
HDL-C levels of treated diabetic groups were 
comparable to the healthy untreated groups 
(Figure 2). Fasting blood sugar levels (FBG) and 
lipid profiles were strongly correlated in the 
diabetic untreated group (DU) while FBG values 
of the methanol root extract treated group (DTM) 
correlated negatively with TC, TAG and VLDL-C 
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Table 3: Effect of oral administration of methanolic extract of M. jalapa roots on liver biochemical indices of 
experimental rats.  
Groups TP (g/dL) Albumin (g/dL) ALT (U/l) AST (U/l) 
DU 43.74±2.67a 2.35±0.20ab 43.63±3.20a 149.62±4.71a 
HU 21.93±4.60b 2.17±0.07b 12.00±1.41b 124.41±8.79b 
HTM 46.09±6.35a 2.27±0.05b 15.83±2.86b 134.80±4.45b 
DTM 39.04±4.39a 2.29±0.06b 26.75±5.32c 125.45±1.54b 
DTS 42.36±3.10a 2.57±0.11a 43.00±0.82a 150.89±2.95a 
Data are expressed as mean ± standard deviation, n=5. Values bearing the same superscript within a particular column do not 
differ significantly (P>0.05) while values bearing different superscript within a particular column differ significantly (p<0.05). 
Key: DU: Diabetic untreated rats (diabetic control); HU: Healthy untreated rats (normal control); HTM: Healthy rats treated with 





Figure 2: Lipid profile parameters of 
experimental animals treated with methanol root 
extracts of M. jalapa 
Key: DU: Diabetic untreated rats (diabetic control); HU: 
Healthy untreated rats (normal control); HTM: Healthy rats 
treated with M. jalapa extract; DTM: Diabetic treated with 
M. jalapa extract; DTS: Diabetic treated with standard drug 
 
DISCUSSION 
A sustained hyperglycemic state has long been 
recognized as underlying cause of chronic 
disturbances often seen in diabetes. The 
mobilization of fuel molecules to compensate for 
energy charge in insulin dependent cells signals 
failure in transport processes involved in cellular 
uptake of glucose. In response, cellular dynamics 
shift in favor of anabolic pathways leading to 
biosynthesis of glucose which complicates 
further, the blood glucose threshold. As 
demonstrated in this study, the methanol root 
extract of M. jalapa showed a blood glucose 
lowering effect (Table 1). A progression towards 
euglycemic state was observed following 
treatment with 200 mg/Kg body weight of the 
extract. The blood glucose lowering mechanism 
most probably differs from that observed for the 
standard drug metformin as shown in Table 2, 
where postprandial glucose remained elevated 
(12.26±3.93 mmol/L) in the diabetic group treated 
with metformin compared with that observed for 
diabetic group treated with the extract ( DTM = 
8.60±2.20 mmol/L) as at Day 10. Oral 
hypoglycemics lower blood glucose by different 
mechanisms (Bosenberg and Van Zyl, 2008). 
Metformin requires residual insulin activity but 
has minimal effect on postprandial glucose (Lund 
et al., 2009). Zhou et al. (2012b) demonstrated 
ethanolic extract of M. jalapa roots had 
hypoglycemic and hypolipidemic effects in 
streptozotocin induced diabetes in mice and 
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present in the root of the plant most probably 
contributes to the observed effects (Zhou et al., 
2013). It was proposed that trigonelline 
influenced the GLP-1 receptor/p38 mitogen 
activated protein kinases signaling pathway 
(Zhou and Zhou, 2012b). The DPP4 and α-
glucosidase inhibitory potentials of this 
compound in both plasma and small intestine 
have also been reported (Hamden et al., 2013). 
The regulatory effects of the extract on 
postprandial glucose as demonstrated in this 
study support the insulinotropic and/or DPP4 
inhibitory mechanisms, both of which are 
important in down regulating glucagon release. 
These mechanisms appear to be beneficial to 
diabetics with residual insulin activity which is 
typical of type 2 diabetes mellitus.  Differences in 
the glucose levels postprandial (Table 2) and the 
observed marked difference (p<0.05) between 
FBS and 2HPP (Figure 1) for all the groups 
except the diabetic untreated group (DU) 
suggests a mechanism of action of the extract 
different from that of metformin. The extract may 
have a stimulatory activity for insulin or enhance 
secretion or prolong the activity of GLP-1 peptide 
(Zhou et al., 2012b). 
 
One of the actions of the hormone glucagon is 
the stimulation of lipolysis as a carbon source in 
gluconeogenesis. The observed drop in TAGs of 
diabetic group treated with the extract (78.18 
mg/dL) when compared with untreated diabetic 
group (125.76 mg/dL) suggest an extract activity 
that promotes glucose utilization in meeting the 
energy needs of insulin dependent cells. FBS 
versus TAG and VLDL-C were observed to 
correlate negatively (Table 4). According to Khan 
et al. (2007), FBS exhibits a direct positive 
correlation with TC, TG, and VLDL but inverse 
HDL in diabetics. Similarly, a negative correlation 
of -0.14 (Table 4) between FBS and triglycerides 
indicates improvements in fuel molecule 
utilization thereby down regulating the need for 
lipolysis hence minimal TAGs mobilization. FBS 
of diabetic (DU) and healthy (HU) groups 
correlated positively with TGs, HDL and VLDL 
(Table 4). However, the correlation was stronger 
in the DU group due to derangements in 
hormonal regulatory mechanisms. Healthy 
animals are better able to regulate energy 
balance depending on metabolic needs. Although 
not demonstrated in this study, it is however 
evident that glucose uptake may play a role in the 
slow progression to dyslipidemia as observed in 
diabetic group treated with methanol root extract 
of M. jalapa suggestive of a balanced ATP : ADP 




Table 4: Correlation of effect oral administration of methanol extract of M. jalapa roots on FBS and Lipid 
profile of experimental animals 
GROUPS TC TAG HDL-C VLDL-C 
DU 0.81 0.83 0.86 0.84 
HU -0.13 0.23 0.69 0.47 
HTM 0.53 0.95 -0.32 0.96 
DTM -0.65 -0.14 0.46 -0.13 
DTS -0.10 0.40 -0.02 0.31 
Key: DU: Diabetic untreated rats (diabetic control); HU: Healthy untreated rats (normal control); HTM: Healthy rats treated with 








Normo-glycemia and a generally slow 
progression to dyslipidemia were influenced by 
administration of Mirabilis jalapa root methanol 
extract to alloxan induced diabetic rats. The plant 
was also demonstrated to have postprandial 
hypoglycemic effect with a possible mechanism 
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